The present study is the first of its type to approach the clinical, evolutionary and immunophenotypic correlations between p14–p16 immunohistochemical testing, CDKN2A molecular biology pattern, familial melanoma and spontaneous MPM in a cohort of Romanian patients. The gene discussed is CDKN2A; the disease is familial melanoma.